BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 31841257)

  • 1. The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.
    Lapirow D; La Gerche A; Toro C; Masango E; Costello B; Porello E; Ludlow L; Marshall G; Trahair T; Mateos M; Lewin J; Byrne J; Boutros R; Manudhane R; Heath J; Ayer J; Gabriel M; Walwyn T; Saundankar J; Forsey J; Le H; Mason K; Celermajer D; Downie P; Walker R; Holland L; Martin M; McLeman L; Diamond Y; Marcocci M; Donath S; Cheung M; Elliott DA; Conyers R
    Intern Med J; 2021 Feb; 51(2):229-234. PubMed ID: 31841257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-toxicity among patients with sarcoma: a cardio-oncology registry.
    Shamai S; Rozenbaum Z; Merimsky O; Derakhshesh M; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Laufer-Perl M
    BMC Cancer; 2020 Jun; 20(1):609. PubMed ID: 32605637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy.
    Laufer-Perl M; Arnold JH; Mor L; Amrami N; Derakhshesh M; Moshkovits Y; Sadeh B; Arbel Y; Topilsky Y; Rozenbaum Z
    Clin Res Cardiol; 2020 Feb; 109(2):255-262. PubMed ID: 31214777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: A Cardio-Oncology Registry.
    Laufer-Perl M; Mor L; Milwidsky A; Derakhshesh M; Amrami N; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Rozenbaum Z
    Isr Med Assoc J; 2020 Sep; 22(9):564-568. PubMed ID: 33236555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology.
    Lancellotti P; Anker SD; Donal E; Edvardsen T; Popescu BA; Farmakis D; Filippatos G; Habib G; Maggioni AP; Jerusalem G; Galderisi M
    Eur Heart J Cardiovasc Imaging; 2015 May; 16(5):466-70. PubMed ID: 25744342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients.
    Zhou Y; Hou Y; Hussain M; Brown SA; Budd T; Tang WHW; Abraham J; Xu B; Shah C; Moudgil R; Popovic Z; Cho L; Kanj M; Watson C; Griffin B; Chung MK; Kapadia S; Svensson L; Collier P; Cheng F
    J Am Heart Assoc; 2020 Dec; 9(23):e019628. PubMed ID: 33241727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point?
    Conyers R; Costello B; La Gerche A; Tripaydonis A; Burns C; Ludlow L; Lange P; Ekert P; Mechinaud F; Cheung M; Martin M; Elliot D
    Intern Med J; 2017 Oct; 47(10):1166-1172. PubMed ID: 28485067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacology of cardio-oncology: a novel interdisciplinary platform for basic and translational research].
    Sase K
    Nihon Yakurigaku Zasshi; 2020; 155(3):179-184. PubMed ID: 32378640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiotoxicity of Cancer Chemotherapy - Mechanisms and Therapeutic Approach].
    Akazawa H
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2058-2063. PubMed ID: 29361617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and Design of the Cessation Of Pharmacotherapy In Recovered Chemotherapy-induced cardioToxicity (COP-RCT): A Pilot Study.
    Yu C; Negishi T; Pathan F; Sverdlov A; Thomas L; Shirazi M; Koo CY; Tan LL; Miyazaki S; Negishi K
    Heart Lung Circ; 2024 May; 33(5):753-757. PubMed ID: 37949748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cardiovascular magnetic resonance imaging in cardio-oncology.
    Saunderson CED; Plein S; Manisty CH
    Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):383-396. PubMed ID: 33404058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organization and implementation of a cardio-oncology program.
    Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
    Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating Cardio-Oncology Across the Research Pipeline, Policy, and Practice in Australia-An Australian Cardiovascular Alliance Perspective.
    Singleton AC; Redfern J; Diaz A; Koczwara B; Nicholls SJ; Negishi K; La Gerche A; Playford D; Conyers R; Cehic DA; Garvey G; Williams TD; Hunt L; Doyle K; Figtree GA; Ngo DTM; Sverdlov AL;
    Heart Lung Circ; 2024 May; 33(5):564-575. PubMed ID: 38336544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
    Andres MS; Pan J; Lyon AR
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction.
    Xiao H; Wang X; Li S; Liu Y; Cui Y; Deng X
    Front Cardiovasc Med; 2021; 8():753313. PubMed ID: 34859069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
    Oikonomou EK; Kokkinidis DG; Kampaktsis PN; Amir EA; Marwick TH; Gupta D; Thavendiranathan P
    JAMA Cardiol; 2019 Oct; 4(10):1007-1018. PubMed ID: 31433450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients.
    Vallabhaneni S; Zhang KW; Alvarez-Cardona JA; Mitchell JD; Steen H; Woodard PK; Lenihan DJ
    Int J Cardiovasc Imaging; 2021 Oct; 37(10):3003-3017. PubMed ID: 33982196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.
    Chow EJ; Leger KJ; Bhatt NS; Mulrooney DA; Ross CJ; Aggarwal S; Bansal N; Ehrhardt MJ; Armenian SH; Scott JM; Hong B
    Cardiovasc Res; 2019 Apr; 115(5):922-934. PubMed ID: 30768157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.